A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

NCT02737306 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to lack of enrolment..

Conditions

Graft Vs Host Disease

Interventions

DRUG: PRO 140
DRUG: Placebo

Sponsor

CytoDyn, Inc.

Collaborators

[object Object]